glp 1 diabetes GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1R and Diabetes
Description
& Beinborn, M
GLP-1 exerts its main effect by stimulating glucose-dependent insulin release from the pancreatic islets [27]
The growing use of GLP-1 drugs in clinical practice makes these findings particularly significant
Long-term strategy: Weight regain after stopping GLP-1s is well-documented
Among patients with UC, those treated with GLP1RA had lower rates of corticosteroid use (46.6% vs 85.1%), hospitalization (40.9% vs 65.9%), intestinal resection (6.52% vs 20.8%), and mortality (4.6% vs 22%) compared with controls
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
doi: 10.5662/wjm.v12.i4.246
